The National Medical Products Administration (NMPA) is the Chinese agency for regulating drugs and medical devices (formerly the China Food and Drug Administration or CFDA). The predecessor to the NMPA was initially founded in 1998 to oversee drugs and medical devices. When it was given jurisdiction over food in 2003, it was renamed the State Food and Drug Administration and reported to the State Council. In 2018, restructuring removed its oversight of food safety and it is now part of the State Administration for Market Regulation (SAMR). Its responsibilities include drafting laws and regulations for drugs, medical devices, and cosmetics, as well as establishing medical device standards and classification systems. For a full list of responsibilities, please consult this entry on the NMPA website (in Chinese).
The NMPA departments dealing with medical devices are:
A list of NMPA regulations can be found here on our website.
您可能已经听说,欧盟完善的医疗器械法规即将迎来变化。并且您可能有很多疑问。这些变化意味着什么,它们将如何影响您的公司? 欧盟新的医疗器械法规(MDR)将对医疗器械制造商进入欧盟市场的方式以及如何在产品的整个生命周期内维持合规产生重大影响。在这份长达28页的白皮书中,Emergo的
阅读更多